Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma

British Journal of Haematology

Volumn 139, Issue 2, 2007, Pages 217-223

  Ma, Liya ^b,c   Xu, Gaixiang ^b,c   Sotnikova, Anna ^b   Szczepanowski, Monika ^b   Giefing, Maciej ^b,d   Krause, Kristina ^b   Krams, Matthias ^b   Siebert, Reiner ^c   Jin, Jie ^b   Klapper, Wolfram ^a,b  

^a Department of Pathology   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c ZHEJIANG UNIVERSITY   (China)

^d INSTITUTE OF HUMAN GENETICS   (Poland)

Author keywords

Apoptosis; ARHGDIB; Hodgkin lymphoma; LyGDI

Indexed keywords

GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; LYGDI PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; HODGKIN DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; TRANSGENICS;

APOPTOSIS; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, NON-HODGKIN; MIFEPRISTONE; REED-STERNBERG CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TRANSGENES; TUMOR SUPPRESSOR PROTEINS;

EID: 34848854515     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06782.x     Document Type: Article

References (18)

1. Cordell, J.L., Falini, B., Erber, W.N., Ghosh, A.K., Abdulaziz, Z., MacDonald, S., Pulford, K.A., Stein, H. Mason, D.Y. (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). Journal of Histochemistry and Cytochemistry, 32, 219 229.
2. Dovas, A. Couchman, J.R. (2005) RhoGDI: multiple functions in the regulation of Rho family GTPase activities. Biochemical Journal, 390, 1 9.
3. Dutton, A., O'Neil, J.D., Milner, A.E., Reynolds, G.M., Starczynski, J., Crocker, J., Young, L.S. Murray, P.G. (2004) Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death. Proceedings of the National Academy of Science of the United States of America, 101, 6611 6616.
4. Essmann, F., Wieder, T., Otto, A., Muller, E.C., Dorken, B. Daniel, P.T. (2000) GDP dissociation inhibitor D4-GDI (Rho-GDI 2), but not the homologous rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis. Biochemical Journal, 346 (Pt 3 777 783.
5. Heidebrecht, H.J., Buck, F., Steinmann, J., Sprenger, R., Wacker, H.H. Parwaresch, R. (1997) p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M. Blood, 90, 226 233.
6. Jaffe, E., Harris, N., Stein, H. Vardiman, J.W. (2001) Pathology and Genetics of Tumours of Haematopoetic and Lymphoid Tissues. IARC Press, Lyon, France.
7. Kanzler, H., Kuppers, R., Hansmann, M.L. Rajewsky, K. (1996) Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. Journal of Experimental Medicine, 184, 1495 1505.
8. Klapper, W., Qian, W., Schulte, C. Parwaresch, R. (2003) DNA damage transiently increases TRF2 mRNA expression and telomerase activity. Leukemia, 17, 2007 2015.
9. Kuppers, R., Klein, U., Hansmann, M.L. Rajewsky, K. (1999) Cellular origin of human B-cell lymphomas. New England Journal of Medicine, 341, 1520 1529.
10. Kuppers, R., Klein, U., Schwering, I., Distler, V., Brauninger, A., Cattoretti, G., Tu, Y., Stolovitzky, G.A., Califano, A., Hansmann, M.L. Dalla-Favera, R. (2003) Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. Journal of Clinical Investigaton, 111, 529 537.
11. Kwon, K.B., Park, E.K., Ryu, D.G. Park, B.H. (2002) D4-GDI is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells. Experimental Molecular Medicine, 34, 32 37.
12. Lelias, J.M., Adra, C.N., Wulf, G.M., Guillemot, J.C., Khagad, M., Caput, D. Lim, B. (1993) cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins. Proceedings of the National Academy of Science of the United States of America, 90, 1479 1483.
13. Martin-Subero, J.I., Chudoba, I., Harder, L., Gesk, S., Grote, W., Novo, F.J., Calasanz, M.J. Siebert, R. (2002) Multicolor-fiction: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses. American Journal of Pathology, 161, 413 420.
14. Re, D., Kuppers, R. Diehl, V. (2005) Molecular pathogenesis of Hodgkin's lymphoma. Journal of Clinical Oncology, 23, 6379 6386.
15. Straus, S.E., Jaffe, E.S., Puck, J.M., Dale, J.K., Elkon, K.B., Rosen-Wolff, A., Peters, A.M., Sneller, M.C., Hallahan, C.W., Wang, J., Fischer, R.E., Jackson, C.M., Lin, A.Y., Baumler, C., Siegert, E., Marx, A., Vaishnaw, A.K., Grodzicky, T., Fleisher, T.A. Lenardo, M.J. (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood, 98, 194 200.
16. Thomas, R.K., Schmitz, R., Harttrampf, A.C., Abdil-Hadi, A., Wickenhauser, C., Distler, V., Hansmann, M.L., Schultze, J.L., Kuppers, R. Wolf, J. (2005) Apoptosis-resistant phenotype of classical Hodgkin's lymphoma is not mediated by somatic mutations within genes encoding members of the death-inducing signaling complex (DISC). Leukemia, 19, 1079 1082.
17. Ventura, R.A., Martin-Subero, J.I., Jones, M., McParland, J., Gesk, S., Mason, D.Y. Siebert, R. (2006) FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. Journal of Molecular Diagnostics, 8, 141 151.
18. Yin, L., Schwartzberg, P., Scharton-Kersten, T.M., Staudt, L. Lenardo, M. (1997) Immune responses in mice deficient in Ly-GDI, a lymphoid-specific regulator of Rho GTPases. Molecular Immunology, 34, 481 491.